Diagnostear Technologies, Inc.

DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx(TM) Red Eye

DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical

DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count